Amarpreet Singh Sawhney

Visit Website Add Favorites Contact Author

Founder, Chairman Ocular Therapeutix inc.

Education:

MS
The University of Texas, Austin
PhD
The University of Texas, Austin
BE
Indian Institute of Technology, Delhi:

Board Members Memberships

Director
marketRx, Inc.
Chairman
Augmenix, Inc.
Director
Axtria, Inc.
Executive Director
Instylla, Inc.
2006-Present
Founder, Chairman, Chief Executive Officer and President
Ocular Therapeutix, Inc.

 

  • Dr. Amarpreet Sawhney, also known as Amar, Ph.D. is a Co-Founder and Managing Partner of Incept, LLC. Dr. Sawhney
  • founded Ocular Therapeutix, Inc in November 2006 and has been its Chief Executive Officer and President since 2006 and has been its Chairman since June 2014.
  • He served as an Advisor at Axtria, Inc.
  • He served as the President and Chief Executive Officer at Confluent Surgical, Inc.
  • He is the President and Chief Executive Officer at Octux, Inc.
  • He founded Augmenix, Inc. and served as its Chief Executive Officer and President.
  • He is the Founder, Chief Executive Officer and President at Ocular Therapeutix Inc.
  • He founded Access Closure, Inc. and Octux, Inc.
  • He co-founded Confluent Surgical, Inc. in 1998.
  • Dr. Sawhney was the Technology Founder at Focal Inc. of Lexington, Massachusetts (acquired by Genzyme).
  • He co-invented Novacell of Santa Ana, California. He serves as the Chairman of Augmenix, Inc.
  • He was the Chairman of marketRx, Inc. He serves as Executive Director for Instylla, Inc.
  • He has been a Director of Ocular Therapeutix, Inc. since 2006.
  • He serves as a Director of Axtria, Inc.
  • He serves as a Director of Confluent Surgical, Inc. and marketRx, Inc.
  • Dr. Sawhney served as Board Member of Octux, Inc., Augmenix, Inc., and Incept LLC. He served as a Director of Access Closure, Inc. and Focal Inc.
  • He personally holds over 35 patents and has authored over 85 publications and scientific abstracts.
  • He has been recognized by several awards including the MIT Global Indus Technovators award and the E&Y Regional Entrepreneur of the year award. His innovations are the subject of almost 100 issued and pending patents in biomaterials.
  • His inventions include “first-of-a-kind” surgical sealants to be approved by the Food and Drug Administration.
  • Dr. Sawhney holds a Ph.D. and a M.S. in Chemical Engineering from the University of Texas at Austin.
  • He holds a B. Tech. in Chemical Engineering from the Indian Institute of Technology, New Delhi.

Profession/Designation Entrepreneur
Location USA
LinkedIn Visit Link Here
Website Link Visit Link Here
Category